A phase II study of lapatinib and bevacizumab as treatment for HER2-overexpressing metastatic breast cancer
暂无分享，去创建一个
C. Hudis | S. Franco | M. Arbushites | H. Rugo | A. Stopeck | John W. Park | M. Dickler | A. Glencer | B. Nulsen | S. Lahiri | Janet H. Scott | A. Jo Chien | bullet A Jo Chien | bullet Soumi | Lahiri bullet | bullet Clifford | Hudis bullet | S. Franco